Brighton Jones’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
Brighton Jones's SMMT Position: Q3 2026 in Review
Brighton Jones opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 12,240 shares worth $207K. The stake represents ﹤0.01% of the portfolio and ranks #1256 among its holdings.
295 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- Brighton Jones held 12,240 shares of Summit Therapeutics worth $207K as of Q3 2026.
- Summit Therapeutics was a new Brighton Jones position in Q3 2026.
- Summit Therapeutics made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1256 holding.
- 295 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.